Pediatric oncology discharges with febrile neutropenia: Variation in location of care

Elysia Alvarez, Lisa J. Chamberlain, Catherine Aftandilian, Olga Saynina, Paul Wise

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We examined the use of Pediatric Cancer Specialty Centers (PCSCs) over time and the length of stay (LOS) in pediatric oncology patients with a diagnosis of febrile neutropenia. PCSCs were defined as Children's Oncology Group and California Children's Services designated centers. We performed a retrospective analysis on all discharges of pediatric (0 to 18) oncology patients with febrile neutropenia in California (1983 to 2011) using the private Office of Statewide Health Planning and Development database. We examined influence of age, sex, race/ethnicity, payer, income, distance, tumor type, and complications on utilization of PCSCs and LOS (SAS 9.2). Analysis of 24,559 pediatric oncology febrile neutropenia discharges showed hospitalizations in PCSCs increasing from 48% in 1983 to 94% in 2011. The adjusted regression analysis showed decreased PCSC utilization for ages 15 to 18, Hispanic patients, and those living >40 miles away. The median PCSC LOS was 9 days compared with 7 days at a non- PCSC (P>0.0001). Discharge from a PCSC was associated with a LOS >8 days after controlling for complications. Inpatient PCSC care for febrile neutropenia in California has increased since 1983. Receiving care at a PCSC is influenced by age, tumor type, ethnicity, geography, and complications.

Original languageEnglish (US)
Pages (from-to)e1-e7
JournalJournal of Pediatric Hematology/Oncology
Volume39
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Febrile Neutropenia
Pediatrics
Neoplasms
Length of Stay
Health Planning
Geography
Hispanic Americans
Inpatients

Keywords

  • Febrile neutropenia
  • Inpatient utilization
  • Pediatric oncology

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Pediatric oncology discharges with febrile neutropenia : Variation in location of care. / Alvarez, Elysia; Chamberlain, Lisa J.; Aftandilian, Catherine; Saynina, Olga; Wise, Paul.

In: Journal of Pediatric Hematology/Oncology, Vol. 39, No. 1, 01.01.2017, p. e1-e7.

Research output: Contribution to journalArticle

Alvarez, Elysia ; Chamberlain, Lisa J. ; Aftandilian, Catherine ; Saynina, Olga ; Wise, Paul. / Pediatric oncology discharges with febrile neutropenia : Variation in location of care. In: Journal of Pediatric Hematology/Oncology. 2017 ; Vol. 39, No. 1. pp. e1-e7.
@article{daf51c0d3d74440c9718a474477346f1,
title = "Pediatric oncology discharges with febrile neutropenia: Variation in location of care",
abstract = "We examined the use of Pediatric Cancer Specialty Centers (PCSCs) over time and the length of stay (LOS) in pediatric oncology patients with a diagnosis of febrile neutropenia. PCSCs were defined as Children's Oncology Group and California Children's Services designated centers. We performed a retrospective analysis on all discharges of pediatric (0 to 18) oncology patients with febrile neutropenia in California (1983 to 2011) using the private Office of Statewide Health Planning and Development database. We examined influence of age, sex, race/ethnicity, payer, income, distance, tumor type, and complications on utilization of PCSCs and LOS (SAS 9.2). Analysis of 24,559 pediatric oncology febrile neutropenia discharges showed hospitalizations in PCSCs increasing from 48{\%} in 1983 to 94{\%} in 2011. The adjusted regression analysis showed decreased PCSC utilization for ages 15 to 18, Hispanic patients, and those living >40 miles away. The median PCSC LOS was 9 days compared with 7 days at a non- PCSC (P>0.0001). Discharge from a PCSC was associated with a LOS >8 days after controlling for complications. Inpatient PCSC care for febrile neutropenia in California has increased since 1983. Receiving care at a PCSC is influenced by age, tumor type, ethnicity, geography, and complications.",
keywords = "Febrile neutropenia, Inpatient utilization, Pediatric oncology",
author = "Elysia Alvarez and Chamberlain, {Lisa J.} and Catherine Aftandilian and Olga Saynina and Paul Wise",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/MPH.0000000000000716",
language = "English (US)",
volume = "39",
pages = "e1--e7",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Pediatric oncology discharges with febrile neutropenia

T2 - Variation in location of care

AU - Alvarez, Elysia

AU - Chamberlain, Lisa J.

AU - Aftandilian, Catherine

AU - Saynina, Olga

AU - Wise, Paul

PY - 2017/1/1

Y1 - 2017/1/1

N2 - We examined the use of Pediatric Cancer Specialty Centers (PCSCs) over time and the length of stay (LOS) in pediatric oncology patients with a diagnosis of febrile neutropenia. PCSCs were defined as Children's Oncology Group and California Children's Services designated centers. We performed a retrospective analysis on all discharges of pediatric (0 to 18) oncology patients with febrile neutropenia in California (1983 to 2011) using the private Office of Statewide Health Planning and Development database. We examined influence of age, sex, race/ethnicity, payer, income, distance, tumor type, and complications on utilization of PCSCs and LOS (SAS 9.2). Analysis of 24,559 pediatric oncology febrile neutropenia discharges showed hospitalizations in PCSCs increasing from 48% in 1983 to 94% in 2011. The adjusted regression analysis showed decreased PCSC utilization for ages 15 to 18, Hispanic patients, and those living >40 miles away. The median PCSC LOS was 9 days compared with 7 days at a non- PCSC (P>0.0001). Discharge from a PCSC was associated with a LOS >8 days after controlling for complications. Inpatient PCSC care for febrile neutropenia in California has increased since 1983. Receiving care at a PCSC is influenced by age, tumor type, ethnicity, geography, and complications.

AB - We examined the use of Pediatric Cancer Specialty Centers (PCSCs) over time and the length of stay (LOS) in pediatric oncology patients with a diagnosis of febrile neutropenia. PCSCs were defined as Children's Oncology Group and California Children's Services designated centers. We performed a retrospective analysis on all discharges of pediatric (0 to 18) oncology patients with febrile neutropenia in California (1983 to 2011) using the private Office of Statewide Health Planning and Development database. We examined influence of age, sex, race/ethnicity, payer, income, distance, tumor type, and complications on utilization of PCSCs and LOS (SAS 9.2). Analysis of 24,559 pediatric oncology febrile neutropenia discharges showed hospitalizations in PCSCs increasing from 48% in 1983 to 94% in 2011. The adjusted regression analysis showed decreased PCSC utilization for ages 15 to 18, Hispanic patients, and those living >40 miles away. The median PCSC LOS was 9 days compared with 7 days at a non- PCSC (P>0.0001). Discharge from a PCSC was associated with a LOS >8 days after controlling for complications. Inpatient PCSC care for febrile neutropenia in California has increased since 1983. Receiving care at a PCSC is influenced by age, tumor type, ethnicity, geography, and complications.

KW - Febrile neutropenia

KW - Inpatient utilization

KW - Pediatric oncology

UR - http://www.scopus.com/inward/record.url?scp=85001969686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85001969686&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000000716

DO - 10.1097/MPH.0000000000000716

M3 - Article

C2 - 27918351

AN - SCOPUS:85001969686

VL - 39

SP - e1-e7

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 1

ER -